Keira A Fieldhouse Samantha Ukaibe Erika L Crowley Reena Khanna Ashley O'Toole Melinda J Gooderham
10.7573/dic.2020-2-1
Drugs Context
2020 Apr 21;9:2020-2-1.
crohn’s disease il-17 inhibitor brodalumab inflammatory bowel disease ixekizumab secukinumab ulcerative colitis
NO-CC CODE
https://pubmed.ncbi.nlm.nih.gov/32362930/
Review
PMC7185907
32362930
Inflammatory bowel disease in patients with psoriasis treated with interleukin-17 inhibitors
2020